Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2000
03/09/2000CA2340617A1 Genes associated with neurotransmitter processing
03/09/2000CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000CA2340592A1 Phelix: a testis-specific protein expressed in cancer
03/09/2000CA2340462A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000CA2337869A1 Method for labeling biopolymers using isotopes
03/09/2000CA2281035A1 Dsba/dsbb/dsbc/dsbd expression plasmid
03/09/2000CA2249657A1 Novel compounds
03/08/2000EP0984066A2 Activator for methanol dehydrogenase and gene thereof
03/08/2000EP0984062A1 Production of human erythropoietin
03/08/2000EP0984023A1 Cell surface molecule mediating cell adhesion and signal transmission
03/08/2000EP0983767A1 Preventives or remedies for sensitized t cell-related diseases containing il-6 antagonists as the active ingredient
03/08/2000EP0983358A1 New human dp1 homolog
03/08/2000EP0983357A1 Modulators of tissue regeneration
03/08/2000EP0983356A1 Smad2 phosphorylation and interaction with smad4
03/08/2000EP0983355A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
03/08/2000EP0983354A2 Neurotrophic factor receptors
03/08/2000EP0983351A1 Nucleic acid binding proteins
03/08/2000EP0983350A1 Nucleic acid binding proteins
03/08/2000EP0983349A1 Nucleic acid binding polypeptide library
03/08/2000EP0983343A1 E. coli, salmonella or hafnia autoinducers
03/08/2000EP0983302A1 Mutated okt3 antibody
03/08/2000EP0983297A1 New echinocandine derivatives with antimicrobial activity
03/08/2000EP0983293A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0833834B1 Dna sequence and encoded mammary-specific breast cancer protein
03/08/2000EP0804596A4 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
03/08/2000EP0672136B1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions
03/08/2000EP0656062B1 Dorsal tissue affecting factor and compositions
03/08/2000EP0619843B1 Icams immunoglobulin constant region soluble fusion proteins
03/08/2000CN1246799A Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
03/07/2000US6034229 BMP-15 compositions
03/07/2000US6034224 Contacting a somatotropin with a c 10-18 acylglutamate detergent composition and water and adjusting the ph of the somatotropin solution
03/07/2000US6034223 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof
03/07/2000US6034222 Method for the separation of recombinant pro-factor IX from recombinant factor IX
03/07/2000US6034221 Reduced side effects
03/07/2000US6034063 Human phosphatidylinositol transfer protein gamma
03/07/2000US6034061 Forming chondrocyte tissue in animal; administering bone morphogenic protein
03/07/2000US6034060 Peptide having an ability to promote the activation of protein C by thrombin
03/07/2000US6033903 Method of expressing and secreting soluble extracellular domains of human gonadotropin hormone receptors
03/07/2000US6033898 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene
03/07/2000US6033879 Process for the preparation of substituted aryl lactic acid containing cyclodepsipeptides with 24 ring atoms
03/07/2000US6033876 The antibodies may be used for diagnosis, or conjugated to a toxin to produce an immunotoxin.
03/07/2000US6033875 Method of improved production of insulin-like growth factor
03/07/2000US6033874 CRY1C polypeptides having improved toxicity to lepidopteran insects
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000US6033869 Diagnosis, prevention, and treatment of disorders associated with aberrant cellular development and differentiation and inflammation.
03/07/2000US6033865 Human n-methyl-d-aspartate receptor type 1 subunits, DNA encoding same and uses therefor
03/07/2000US6033863 Monoclonal antibodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids
03/07/2000US6033856 Promoter of the cdc25B gene, its preparation and use
03/07/2000CA1340919C Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
03/02/2000WO2000011193A1 Novel proteases and dnas encoding the same
03/02/2000WO2000011183A2 Chlamydia antigens and corresponding dna fragments and uses thereof
03/02/2000WO2000011179A1 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM)
03/02/2000WO2000011175A1 Genetic method for the expression of polyproteins in plants
03/02/2000WO2000011174A1 Human il-1 epsilon dna and polypeptides
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011170A1 14400 receptor, a g-protein coupled receptor
03/02/2000WO2000011169A2 Human cell signaling proteins (csig)
03/02/2000WO2000011167A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000WO2000011166A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family
03/02/2000WO2000011163A1 Dcr5, a bmp-binding protein, and applications thereof
03/02/2000WO2000011161A1 Novel collectin
03/02/2000WO2000011153A1 Monoclonal antibody inhibiting the liberation of cell atp and hybridomas producing the monoclonal antibody
03/02/2000WO2000011152A1 Streptavidin mutants having secondary functional domains
03/02/2000WO2000011037A1 Monoclonal antibodies specific for streptococcus mutans, and uses thereof
03/02/2000WO2000011036A1 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120
03/02/2000WO2000011033A2 Expression and export of angiostatin and endostatin as immunofusins
03/02/2000WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof
03/02/2000WO2000011015A1 Secreted proteins and polynucleotides encoding them
03/02/2000WO2000011014A1 49 human secreted proteins
03/02/2000WO2000010603A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000WO2000010601A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
03/02/2000WO2000010599A2 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
03/02/2000WO2000010583A1 Human histone deacetylase gene hd4
03/02/2000WO2000010578A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
03/02/2000WO1999063090A3 Protease inhibitor peptides
03/02/2000WO1999061651A3 Methods for producing a polypeptide by modifying the copy number of a gene
03/02/2000WO1999061614A3 Human socs proteins
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999058558A3 Cell signaling proteins
03/02/2000WO1999057271A3 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
03/02/2000WO1999054465A3 Gene encoding syntaxin interacting protein
03/02/2000WO1999045108A3 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
03/02/2000WO1999045031A3 Cd147 binding molecules as therapeutics
03/02/2000WO1999042596A3 Phosphodiesterase 10
03/02/2000DE19839736A1 Humane monoklonale Antikörper gegen Inselzellantigen IA-2 Human monoclonal antibodies against islet cell antigen IA-2
03/02/2000DE19839491A1 Verfahren zur Markierung von Biopolymeren mit Isotopen Methods for labeling of biopolymers with isotopes
03/02/2000DE19827457C1 Strukturprotein von AAV, seine Herstellung und Verwendung AAV structural protein, its preparation and use
03/02/2000CA2341637A1 Chlamydia antigens and corresponding dna fragments and uses thereof
03/02/2000CA2341558A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000CA2340884A1 49 human secreted proteins
03/02/2000CA2340787A1 An anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120
03/02/2000CA2340692A1 Immunogenic .beta.-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
03/02/2000CA2340616A1 Secreted proteins and polynucleotides encoding them
03/02/2000CA2340595A1 Streptavidin mutants having secondary functional domains
03/02/2000CA2340466A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
03/02/2000CA2340457A1 14400 receptor, a g-protein coupled receptor
03/02/2000CA2340334A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family
03/02/2000CA2340318A1 Monoclonal antibody inhibiting the liberation of cell atp and hybridomas producing the monoclonal antibody
03/02/2000CA2340277A1 Human rna-associated proteins
1 ... 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 ... 1125